eclipse-of-earth-world
1 January 2012PharmaMike Snodin and Michael Pears

A brave new world for supplementary protection certificates?

Supplementary protection certificates (SPCs) are a unique form of intellectual property that came into existence in Europe in 1993. They provide an extended period of monopoly to patent holders who experience substantially reduced effective patent terms due to the need to obtain regulatory approval prior to selling their patented medicinal or plant protection products.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Pharma
27 August 2026   Turkish regulators are investigating the drugmaker over its efforts to protect its drug from generic rivals—conduct that may sound familiar to European competition watchers.
Pharma
21 August 2026   Under the terms of the agreement, which resolves all patent litigation between the biopharma rivals, Teva now has a launch date for its own version of Aurinia's Lupkynis.
Pharma
20 August 2026   A reported deal with an Indian manufacturer could clear a path for a future generic launch as the Korean drugmaker leverages one of its biggest US products.